<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82680">
  <stage>Registered</stage>
  <submitdate>19/03/2008</submitdate>
  <approvaldate>4/04/2008</approvaldate>
  <actrnumber>ACTRN12608000163303</actrnumber>
  <trial_identification>
    <studytitle>Minimally Invasive Surgery tibial base plate study</studytitle>
    <scientifictitle>Radiostereometric Analysis (RSA), Of The Genesis II Minimally Invasive Surgery (MIS) Tibial Base Plate</scientifictitle>
    <utrn />
    <trialacronym>MIS Tib</trialacronym>
  </trial_identification>
  <conditions>
    <healthcondition>Osteoarthritis of the knee</healthcondition>
    <healthcondition>osteoarthritis</healthcondition>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Osteoarthritis</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Genesis II MIS Tibial Base Plate

As the advantages of minimally invasive techniques have become apparent, increasing numbers
of surgeons are seeking to incorporate MIS into their practices  without clinical compromises.
Instrumentation improvement has allowed surgery to be performed through small incisions
with a reduction in soft tissue trauma. The next step in the evolution of MIS lies in the modification
of the implants themselves.
The GENESIS II Minimally Invasive Tibial Baseplate represents the new standard in minimally
invasive implants. Built on the successful implant design history and proven track record of GENESIS,
the MIS baseplate has been specifically designed and tested for minimally invasive techniques.
Available for use with both Cruciate Retaining and Posterior
Stabilized components, the GENESIS II MIS Tibial Baseplate
features a shorter post (20 mm) and fins. This allows easier
insertion through a small incision without tibial subluxation,
resulting in less stress on the incision itself and the extensor
mechanism, as well as less soft tissue trauma.
The MIS baseplate maintains 80% of the GENESIS II baseplates fins to ensure that there is no compromise in fixation and
rotational stability.</interventions>
    <comparator>Standard GENESIS II Tibial base plate

The GENESIS II tibial components
were designed to create solutions
that maximize long-term function
by improving fixation and reducing
osteolysis-causing debris.
The result is a complete set of
implant choices that includes a
nonporous tibial tray and a porous
tibial tray, as well as cruciate
retaining and posterior stabilized
all-poly tibial implants. The improved anatomical shape
combine to maximize cortical
coverage,providing an optimized
foundation for reducing posteromedial
impingement and
polyethylene wear.
The posterior fins have been
enlarged to maximize fixation and
rotational stability of the nonporous
tibial tray. The porous tibial
implant is designed with four
finned spikes, four 6.5 mm cancellous
screws, and the option of a
metaphyseal stem to maximize
initial fixation.8
The proximal surface of the
metal tibial implants is polished to
minimize debris generation at this
articulation surface, while the
dovetail locking mechanism provides
a strong, peripheral lock to
reduce micromotion between the
tray and the articular insert.</comparator>
    <control>Historical</control>
    <interventioncode>Treatment: Devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Radiostereometric Xray analysis</outcome>
      <timepoint>6, 12, 24 months</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Patient functional outcome and satisfaction
European quality of life 5 dimensions questionnaire, oxford knee score</outcome>
      <timepoint>6, 12 , 24 months</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>	15 physically active subjects diagnosed with osteoarthritis of the knee, who are to undergo total knee replacement surgery
	Informed Consent</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>80</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>	Inflammatory or post trauma arthritis
	Earlier High tibial osteotomy (HTO)
	Severe osteoporosis
	Steroid treatment, 
	Unclear reason for pain.  
	Previous infection.
	Poor understanding of English. 
	Body Mass Index &gt;35, &gt; 80 years, &lt; 80° flexion, &gt; 15° Fixed Flexion Deformity or varus/ valgus deformity</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence>NA</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/04/2008</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>15</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Rob Molanr</primarysponsorname>
    <primarysponsoraddress>4 Short St Kogarah nsw 2217</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname>Rob Molnar</fundingname>
      <fundingaddress>4 Short St Kogarah nsw 2217</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Rob Molnar</sponsorname>
      <sponsoraddress>4 Short St Kogarah nsw 2217</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>We aim to measure the migration pattern of the tibial base plats using RSA.
We would also like to compare RSA and clinical questionnaire data (oxford knee score and EQ5D score) regarding Genesis II MIS tibial base plate to a previous study involving standard Genesis II tibial base plates</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Not yet submitted</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname />
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate>20/03/2008</ethicsubmitdate>
      <ethiccountry />
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Rob Molnar</name>
      <address>4 Short St Kogarah</address>
      <phone>0402730732, 95874720</phone>
      <fax />
      <email>rmolnar@optusnet.com.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Peter Cairns</name>
      <address>4 Short St Kogarah</address>
      <phone>0408615126, 95874720</phone>
      <fax />
      <email>pcairns@orthotrauma.com.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>peter cairns</name>
      <address>4 Short St Kogarah nsw 2217</address>
      <phone>0408615126, 95874720</phone>
      <fax />
      <email>pcairns@orthotrauma.com.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>